Patents Examined by Sudhaker R. Patel
  • 1H-imidazo[4,5-d]pyridazin-7-one, and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
    Patent number: 6518271
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I: and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
    Type: Grant
    Filed: August 9, 2000
    Date of Patent: February 11, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Paul Joseph Gilligan, Rajagopal Bakthavatchalam
  • Heterocyclic substituted pyrazolones
    Patent number: 6455525
    Abstract: The present invention is directed to novel heterocyclic substituted pyrazolones, including pharmaceutical compositions, diagnostic kits, assay standards or reagents containing the same, and methods of using the same as therapeutics. The invention is also directed to intermediates and processes for making these novel compounds.
    Type: Grant
    Filed: October 31, 2000
    Date of Patent: September 24, 2002
    Assignee: Cephalon, Inc.
    Inventors: Jasbir Singh, Rabindranath Tripathy
  • Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
    Patent number: 6180632
    Abstract: This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56lck tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
    Type: Grant
    Filed: November 24, 1998
    Date of Patent: January 30, 2001
    Assignee: Aventis Pharmaceuticals Products Inc.
    Inventors: Michael R. Myers, Wei He, Alfred P. Spada, Martin P. Maguire
  • Heterocyclically substituted benzamides and their use in fighting diseases
    Patent number: 6172072
    Abstract: Heterocyclically substituted benzamides of the formula I are described, where R1, R2, R3, R4, R5, X, m and n have the meanings given in the description. The novel compounds are useful for controlling diseases.
    Type: Grant
    Filed: May 19, 1999
    Date of Patent: January 9, 2001
    Assignee: BASF Aktiengesellschaft
    Inventors: Wilfried Lubisch, Achim Möller, Hans-Jörg Treiber